---
title: "達視光學股票警報：Halper Sadeh LLC 正在調查達視光學公司的出售是否公平對待股東"
description: "紐約，2025 年 9 月 11 日（GLOBE NEWSWIRE）-- 投資者權益律師事務所 Halper Sadeh LLC 正在調查 STAAR Surgical Company（STAA）以每股 28.00 美元現金出售給愛爾康（Alcon）是否對 STAAR 的股東公平"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/256914386.md"
published_at: "2025-09-11T11:38:35.000Z"
---

# 達視光學股票警報：Halper Sadeh LLC 正在調查達視光學公司的出售是否公平對待股東

> 紐約，2025 年 9 月 11 日（GLOBE NEWSWIRE）-- 投資者權益律師事務所 Halper Sadeh LLC 正在調查 STAAR Surgical Company（STAA）以每股 28.00 美元現金出售給愛爾康（Alcon）是否對 STAAR 的股東公平

NEW YORK, Sept. 11, 2025 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of STAAR Surgical Company STAA to Alcon for $28.00 per share in cash is fair to STAAR shareholders.

### Related Stocks

- [STAA.US - 達視光學](https://longbridge.com/zh-HK/quote/STAA.US.md)
- [ALC.US - 愛爾康](https://longbridge.com/zh-HK/quote/ALC.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Alcon Scraps Takeover Plans for US-based Staar Surgical | Alcon Scraps Takeover Plans for US-based Staar Surgical | [Link](https://longbridge.com/zh-HK/news/271736841.md) |
| Alcon Recalls Certain Custom Pak Ophthalmic Procedure Packs | Alcon Recalls Certain Custom Pak Ophthalmic Procedure Packs | [Link](https://longbridge.com/zh-HK/news/271463264.md) |
| Alcon AG Completes $750 Million Unit Buyback | Alcon AG has completed a $750 million share repurchase program, acquiring 9,301,877 shares, which is 1.9% of its current | [Link](https://longbridge.com/zh-HK/news/273133978.md) |
| Alcon Ups Takeover Bid for Staar Surgical Under Amended Merger Deal | Alcon Ups Takeover Bid for Staar Surgical Under Amended Merger Deal | [Link](https://longbridge.com/zh-HK/news/269105936.md) |
| STAAR Surgical Faces Shareholder Backlash Over Proposed Sale to Alcon | STAAR Surgical faces shareholder backlash over its proposed acquisition by Alcon Inc. Concerns have been raised about th | [Link](https://longbridge.com/zh-HK/news/269859424.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。